R. G. Dietzgen, Family rhabdoviridae, Virus taxonomy: ninth report of the international committee on taxonomy of viruses, pp.686-714, 2011.

M. J. Schnell, The cell biology of rabies virus: using stealth to reach the brain, Nat Rev Microbiol, vol.8, issue.1, pp.51-61, 2010.

N. Johnson, A. Fooks, and K. Mccoll, Human rabies case with long incubation, Australia. Emerging Infect Diseases, vol.14, issue.12, pp.1950-1951, 2008.

, Expert Consultation on Rabies, World Health Organ Tech Rep Ser WHO, pp.1-139, 2013.

L. Both, Passive immunity in the prevention of rabies, Lancet Infect Dis, vol.12, issue.5, pp.397-407, 2012.

P. Shantavasinkul and H. Wilde, Postexposure prophylaxis for rabies in resourcelimited/poor countries, Adv Virus Res, vol.79, pp.291-307, 2011.

M. Uwanyiligira, Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations, Clin Infect Dis, vol.55, issue.2, pp.201-206, 2012.

T. Hemachudha, J. Laothamatas, and C. E. Rupprecht, Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges, Lancet Neurol, vol.1, issue.2, pp.101-110, 2002.

P. Lewis, Y. Fu, and T. L. Lentz, Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures, Muscle Nerve, vol.23, issue.5, pp.720-750, 2000.

M. M. Kaplan, Studies on the local treatment of Wounds for the prevention of rabies, Bull WHO, vol.26, pp.765-75, 1962.

C. A. Hanlon, The incurable wound revisited: progress in human rabies prevention?, Vaccine, vol.19, pp.2273-2282, 2001.

L. Fangtao, Use of serum and vaccine in combination for prophylaxis following exposure to rabies, Rev Infect Dis, vol.10, issue.4, pp.766-70, 1988.

W. M. Pardridge, Biopharmaceutical drug targeting to the brain, J Drug Target, vol.18, issue.3, pp.157-67, 2010.

M. Lafon, Rabies virus receptors, J Neurovirol, vol.11, issue.1, pp.82-89, 2005.

M. Lafon, Rabies virus superantigen, Res Immunol, vol.144, issue.3, pp.209-222, 1993.

T. L. Lentz, Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor, Adv Biochem Psychopharmacol, vol.44, pp.57-71, 1988.

T. L. Lentz, Is the acetylcholine receptor a rabies virus receptor?, Science, vol.215, issue.4529, pp.182-186, 1982.

T. G. Burrage, G. H. Tignor, and A. L. Smith, Rabies virus binding at neuromuscular junctions, Virus Res, vol.2, issue.3, pp.273-89, 1985.

T. L. Lentz, E. Hawrot, and P. T. Wilson, Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor, Proteins, vol.2, issue.4, pp.298-307, 1987.

T. L. Lentz, Rabies virus binding to an acetylcholine receptor alpha-subunit peptide, J Mol Recognit, vol.3, issue.2, pp.82-90, 1990.

P. Kumar, Transvascular delivery of small interfering RNA to the central nervous system, Nature, vol.448, issue.7149, pp.39-43, 2007.

J. Y. Kim, Brain-targeted delivery of protein using chitosan-and RVG peptide-conjugated, pluronic-based nano-carrier, Biomaterials, vol.34, issue.4, pp.1170-1178, 2013.

W. Hwang-do, A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA, Biomaterials, vol.32, issue.21, pp.4968-75, 2011.

L. Xiang, Targeted delivery of large fusion protein into hippocampal neurons by systemic administration, J Drug Target, vol.19, issue.8, pp.632-638, 2011.

A. Fu, Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide, Pharm Res, vol.29, issue.6, pp.1562-1571, 2012.

T. Muller, Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans, PLoS Negl Trop Dis, vol.3, issue.11, p.542, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00460244

L. Both, Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans, FASEB J, vol.27, issue.5, pp.2055-65, 2013.

W. Phoolcharoen, Enhanced transport of plant-produced rabies singlechain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device, Plant Biotechnol J, 2017.

W. Phoolcharoen, Enhanced transport of plant-produced rabies singlechain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device, Plant Biotechnol J, vol.15, issue.10, pp.1331-1340, 2017.

Z. Huang, A DNA replicon system for rapid high-level production of viruslike particles in plants, Biotechnol Bioeng, vol.103, issue.4, pp.706-720, 2009.

J. G. Yamauchi, Characterizing ligand-gated ion channel receptors with genetically encoded Ca2++ sensors, PLoS One, vol.6, issue.1, p.16519, 2011.

B. B. Weksler, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J, vol.19, issue.13, pp.1872-1876, 2005.

M. I. Thoulouze, Rabies virus infects mouse and human lymphocytes and induces apoptosis, J Virol, vol.71, issue.10, pp.7372-80, 1997.

F. Megret, Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis, Vaccine, vol.23, pp.5342-50, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00194658

D. E. Eigenmann, Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies, Fluids Barriers CNS, vol.10, issue.1, p.33, 2013.

K. Morimoto, Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America, Proc Natl Acad Sci, vol.93, issue.11, pp.5653-5661, 1996.

E. Markoutsa, Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line, Eur J Pharm Biopharm, vol.77, issue.2, pp.265-74, 2011.

J. Rip, Liposome technologies and drug delivery to the CNS, Drug Discov Today Technol, vol.20, pp.53-61, 2016.

C. Portioli, Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications, J Biomed Mater Res A, vol.105, issue.3, pp.847-58, 2017.

X. Meng, Pluronic F127 and D-alpha-Tocopheryl Polyethylene Glycol Succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier, Sci Rep, vol.7, issue.1, p.2964, 2017.

C. H. Li, Gold nanoparticles increase endothelial paracellular permeability by altering components of endothelial tight junctions, and increase bloodbrain barrier permeability in mice, Toxicol Sci, vol.148, issue.1, pp.192-203, 2015.

R. J. Boado, Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor, Mol Pharm, vol.7, issue.1, pp.237-281, 2010.

J. Niewoehner, Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle, Neuron, vol.81, issue.1, pp.49-60, 2014.

N. Bien-ly, Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants, J Exp Med, vol.211, issue.2, pp.233-277, 2014.

W. M. Pardridge, Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate, Pharm Res, vol.12, issue.6, pp.807-823, 1995.

R. J. Boado, Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier, Biotechnol Bioeng, vol.99, issue.2, pp.475-84, 2008.

X. Tian, LRP-1-mediated intracellular antibody delivery to the Central Nervous System, Sci Rep, vol.5, p.11990, 2015.

M. Kristensen and B. Brodin, Routes for drug translocation across the blood-brain barrier: exploiting peptides as delivery vectors, J Pharm Sci, 2017.

D. Zhang, J. Wang, and D. Xu, Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drugdelivery systems, J Control Release, vol.229, pp.130-139, 2016.

C. Velasco-aguirre, Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches, Int J Nanomedicine, vol.10, pp.4919-4955, 2015.

Z. Zou, Cre fused with RVG peptide mediates targeted genome editing in mouse brain cells in vivo, Int J Mol Sci, vol.2016, issue.12, p.17

A. Y. Teh, Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco, Plant Biotechnol J, vol.12, issue.3, pp.300-311, 2014.

D. L. Donnelly-roberts and T. L. Lentz, Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor, Pept Res, vol.2, issue.3, pp.221-227, 1989.

M. J. Warrell, The dilemma of managing human rabies encephalitis, Trop Med Int Health, vol.21, issue.4, pp.456-463, 2016.

J. T. Andersen, Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding, J Biol Chem, vol.285, issue.7, pp.4826-4862, 2010.